Founded in 2021, Exsure operates in Enterprise Tech industry. Initially concentrating on developing diagnostic tools for various infectious diseases, the company has since broadened its market to incl...
Funding stage:
Seed
Last funding:
21/01/2025
Total funding:
$344.47K+
Revenue:
Investors
Employee count:
8
Last 90d
8
Last 90d
Web traffic:
2.31K
2.31K
Last 30d
Last 30d
Exsure: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date25 Aug 2025- Funding Events2
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Exsure
As of 26 August 2025, Exsure's equity is held by 5 shareholders, with the top three being Abhishek Dutta, Swastika Paul, and Unicorn India Ventures Fund III.
Abhishek Dutta holds the largest stake in Exsure at 50.0% as of 26 August 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links